📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
COHANCE LIFESCIENCES LIMITEDCOHANCEPharmaceuticals
Open
626
High
627.3
Low
614.2
Close
615.5
Volume
2034527
Exchange
nse
Time
14-Nov-2025

Outlook

Score:  

1.5

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Cohance Lifesciences is  
Normal
Estimated Stoploss of Cohance Lifesciences is ₹  
627.3
Cohance Lifesciences has a  
Bearishℹ
 pattern. 
Formation of  
Normal
 candle pattern indicates the trend direction of Cohance Lifesciences is  
Unpredictableℹ
. 

Trend

Cohance Lifesciences is in  
Downtrendℹ
. 
Price of Cohance Lifesciences is  
Downℹ
 by  

25.83

%. 
Target
Buy @ 

614.2

Sell @ 

903.4

Current @ 

615.5

Volume

Cohance Lifesciences has seen a  
Significantℹ
 rise in volume of trades. 
The volume trend for Cohance Lifesciences is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Cohance Lifesciences is  

Up

 by  

36.66

% 

Valuation

The current market price of Cohance Lifesciences is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 3031cr and total assets worth ₹ 3031cr, the balance sheet of Cohance Lifesciences is:  
Balancedℹ
. 
Cashflow
Cohance Lifesciences has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 38cr

. It is  
Upℹ
 by  

323.53

%. 

(*Mar 2025)

52.65% i.e. ₹ 288cr earned in operatingℹ
46.62% i.e. ₹ 255cr spent in investingℹ
0.55% i.e. ₹ 3cr earned in financingℹ
0.18% i.e. ₹ 1cr earned in otherℹ
Cohance Lifesciences has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 17cr

. It is  
Downℹ
 by  

185

%. 

(*Mar 2024)

48.84% i.e. ₹ 358cr earned in operatingℹ
49.39% i.e. ₹ 362cr spent in investingℹ
1.77% i.e. ₹ 13cr spent in financingℹ
0% in otherℹ
Income
The income of Cohance Lifesciences is  

₹ 571cr

 and  

Profit

 is :  

₹ 66cr

(*Sep 2025)

Cohance Lifesciences Profit is up by:  

21.05

% and Income is Up by:  

36.65

% 

(*Sep 2025)

The income of Cohance Lifesciences is  

₹ 563cr

 and  

Profit

 is :  

₹ 46cr

(*Jun 2025)

Cohance Lifesciences Profit is down by:  

54.22

% and Income is Up by:  

27.95

% 

(*Jun 2025)

The income of Cohance Lifesciences is  

₹ 412cr

 and  

Profit

 is :  

₹ 38cr

(*Mar 2025)

Cohance Lifesciences Profit is up by:  

2.47

% and Income is Up by:  

18.82

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.